Regeneron to highlight scientific advancements across diversified pipeline in difficult-to-treat blood cancers and disorders at ash

Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large b-cell lymphoma

REGN Ratings Summary

REGN Quant Ranking